Pancreatic cancer differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 26: Line 26:
* Imaging: Non-contrast helical CT
* Imaging: Non-contrast helical CT
* Biopsy findings
* Biopsy findings
* Serum IgG4 levels for autoimmune pancreatitis
* For pancreatic NETs:
* For pancreatic NETs:
** Gastrin levels
** Gastrin levels
Line 41: Line 42:
** MRI
** MRI
** MRCP
** MRCP
** USG bile duct
** ERCP
* Biopsy findings
* Biopsy findings
|-
|-
Line 51: Line 54:
** MRI
** MRI
** ERCP
** ERCP
** Upper GI Endoscopy
* Biopsy findings
* Biopsy findings
|-
|-

Revision as of 00:41, 15 November 2017

Pancreatic cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pancreatic Cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pancreatic cancer differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pancreatic cancer differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pancreatic cancer differential diagnosis

CDC on Pancreatic cancer differential diagnosis

Pancreatic cancer differential diagnosis in the news

Blogs on Pancreatic cancer differential diagnosis

Directions to Hospitals Treating Pancreatic cancer

Risk calculators and risk factors for Pancreatic cancer differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Pancreatic cancer must be differentiated from choledocholithiasis, pancreatic pseudocyst, cystic neoplasm and carcinoma of the biliary tract

Differentiating Pancreatic Cancer from other Diseases

The following diseases have a similar presentation as pancreatic cancer:

ORIGIN DISEASES DIFFERENTIATION BASED ON INVESTIGATIONS
Pancreas
  • Chronic pancreatitis
  • Autoimmune pancreatitis
  • Pseudocyst of pancreas
  • Neuroendocrine tumors of pancreas
    • Gastrinoma
    • VIPoma
    • Somatostatinoma
    • Insulinoma
  • Imaging: Non-contrast helical CT
  • Biopsy findings
  • Serum IgG4 levels for autoimmune pancreatitis
  • For pancreatic NETs:
    • Gastrin levels
    • Somatostatin levels
    • Insulin levels
    • Serum electrolytes
Bile duct
  • Choledocholithiasis
  • Cholangiocarcinoma
  • Bile duct strictures
  • Imaging:
    • MRI
    • MRCP
    • USG bile duct
    • ERCP
  • Biopsy findings
Duodenum
  • Ampullary cancer
  • Duodenal cancer
  • Imaging:
    • MRI
    • ERCP
    • Upper GI Endoscopy
  • Biopsy findings
Lymphovascular

tissue

  • Abdominal aortic aneurysm
  • Intestinal ischemia
  • Lymphomas
    • Gastric
    • Pancreatic
  • Imaging:
    • MRI
    • MR Angiography
    • CT Angiography
  • Biopsy for lymphoma
Metastasis
  • Skin(Melanoma)
  • Kidney
  • Breast
  • Colon
  • Liver(Hepatocellular carcinoma)
  • Stomach
  • Imaging:
    • MRI
    • PET scan
    • CT
  • Biopsy
  • Specific markers for different cancers:
    • HCC: AFP
    • Breast: BRCA 1 and 2
    • Colon cancer: CEA
    • Melanoma: S100

References

Template:WH Template:WS